Merck extends Idera collaboration; HIV vaccine failures point to future success; Adults shun flu shot - FierceVaccines: "Some 16,000 African children are being recruited for a clinical trial of a new malaria vaccine. 'This is probably going to be one of the largest studies in infants and in children in Africa.' says Joe Cohen, a vaccine researcher at GlaxoSmithKline. Story
Vical says it has completed enrollment of subjects in a Phase II trial of its therapeutic DNA vaccine designed to prevent cytomegalovirus reactivation and disease in immunosuppressed stem cell transplant recipients. Release"